Mayo Clinic and Vocalis Health Collaborate for Development of...

Mayo Clinic and Vocalis Health Collaborate for Development of AI-Based Vocal Biomarker

Healthcare Tech Outlook | Thursday, November 12, 2020

Mayo Clinic and Vocalis Health, Inc., announced a collaboration to research and develop new voice-based tools that can be used for screening, detecting, and monitoring patient health.

FREMONT, CA: Mayo Clinic and Vocalis Health, Inc have announced a partnership to research and develop new voice-based tools to screen, detect, and monitor patient health. The partnership will start with a study to recognize the vocal biomarkers for pulmonary hypertension (PH) to help the physicians identify and treat PH in their patients.

In the earlier trial with Vocalis Health, the Mayo research team formed a relationship among specific vocal characteristics and PH. Mayo will perform a prospective clinical validation study to develop PH vocal biomarkers further during this new partnership. The clinical validation will use Vocalis Health's proprietary software to operate on any connected voice platform like mobile, computer, or tablet and analyzes patient's health based on voice recordings. After the first stage, the researchers will recognize the vocal biomarkers by targeting more diseases, symptoms, and conditions.

"We have seen the clinical benefits of voice analysis for patient screening throughout the COVID-19 pandemic, and this collaboration presents an opportunity for us to continue broadening our research, beginning with pulmonary hypertension," said Tal Wenderow, CEO of Vocalis Health. "Voice analysis has the potential to help physicians make more informed decisions about their patients in a non-invasive, cost-effective manner. We believe this technology could have important clinical implications for telemedicine and remote patient monitoring in the very near future. We are excited to work with Mayo Clinic and have already started planning clinical trials for additional indications.'

Pulmonary hypertension is a critical condition that causes high blood pressure in the lungs. But since the symptoms are like other heart and lung conditions, most of the time, it is not detected in routine physical exams. In some cases, the traditional blood tests can identify pulmonary hypertension, but often it goes undiagnosed. This strategic collaboration intends to offer an alternative and highly scalable procedure that can be utilized for checking the patients for PH, with the help of a recording of the patient's voice so that it becomes easy to understand their health and the progression of the disease.

Weekly Brief